GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Forward PE Ratio

Synthetic MR AB (XSAT:SYNT) Forward PE Ratio : 51.81 (As of May. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Forward PE Ratio?

Synthetic MR AB's Forward PE Ratio for today is 51.81.

Synthetic MR AB's PE Ratio without NRI for today is 116.67.

Synthetic MR AB's PE Ratio for today is 116.67.


Synthetic MR AB Forward PE Ratio Historical Data

The historical data trend for Synthetic MR AB's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Forward PE Ratio Chart

Synthetic MR AB Annual Data
Trend 2019-12 2020-12 2021-12 2022-12 2023-12 2024-05
Forward PE Ratio
55.56 80.65 93.46 57.47 34.13 49.75

Synthetic MR AB Quarterly Data
2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 55.56 53.48 112.36 43.48 80.65 79.37 92.59 86.21 93.46 83.33 136.99 37.59 57.47 71.94 77.52 30.86 34.13 45.66

Competitive Comparison of Synthetic MR AB's Forward PE Ratio

For the Health Information Services subindustry, Synthetic MR AB's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Forward PE Ratio falls into.



Synthetic MR AB Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Synthetic MR AB  (XSAT:SYNT) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Synthetic MR AB Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines